
Saints Capital
Description
Saints Capital is a distinctive merchant venture capital firm based in San Francisco, with an additional office in London, setting it apart in the venture ecosystem. Established with a primary focus on providing liquidity solutions, the firm specializes in secondary transactions, acquiring venture capital and growth equity interests from limited partners, venture capitalists, corporations, and founders. This unique approach allows them to invest in a diverse range of late-stage private companies, primarily across the technology, healthcare, and consumer sectors. Saints Capital has successfully raised over $1.5 billion in capital across eight dedicated funds, demonstrating a consistent ability to attract significant institutional backing for its specialized investment strategy.
The firm's investment thesis revolves around identifying opportunities where existing shareholders or companies seek liquidity, often due to fund life cycles, strategic shifts, or a desire for partial exits. Saints Capital directly invests in private companies, typically those with established products, revenue streams, and a clear path to further growth or exit. Their expertise lies in structuring complex transactions that provide tailored liquidity solutions, whether through direct equity purchases, portfolio acquisitions, or other structured deals. The firm has completed over 100 transactions, showcasing its active role in facilitating liquidity within the private markets.
Saints Capital's typical investment size for direct stakes ranges from $5 million to over $100 million, reflecting their capacity to engage in significant late-stage and growth equity deals. This flexibility allows them to acquire individual company stakes or larger portfolios of venture capital interests. Their long-standing presence and consistent fundraises, including their latest fund, Saints Capital VIII, underscore their position as a key player in the secondary market, offering a vital alternative path for liquidity in the private investment landscape.
Investor Profile
Saints Capital has backed more than 71 startups, with 0 new investments in the last 12 months alone. The firm has led 10 rounds, about 14% of its total and boasts 34 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Debt Financing, Series D rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Health Care, Medical Device, Medical.
- Typical check size: $5M – $100M.
Stage Focus
- Series Unknown (30%)
- Debt Financing (21%)
- Series D (13%)
- Series C (8%)
- Series E (7%)
- Series B (4%)
- Series A (4%)
- Series G (3%)
- Private Equity (3%)
- Series H (3%)
Country Focus
- United States (92%)
- Israel (8%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Software
- Biotechnology
- Telecommunications
- Manufacturing
- Wireless
- Therapeutics
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.